CLEC9A Polyclonal Antibody

Background:
CLEC9A is a group V C-type lectin-like receptor (CTLR) that functions as an activation receptor and is expressed on myeloid lineage cells.Flow cytometric, Western blot, and deglycosylation analyses showed surface expression of a glycosylated CLEC9A dimer of 40 and 45 kD under reducing conditions. The deglycosylated dimer was approximately 30 and 35 kD. RT-PCR detected CLEC9A expression in most human tissues examined, with highest levels in brain, thymus, and spleen.

Research Area: Immunology, Stem cells

Synonyms:
C type lectin domain family 9, member A, C-type lectin domain family 9 member A, CLC9A, CLEC9A, DNGR1, HEEE9341, PRO34046, UNQ9341

Immunogen: Synthetic peptide of human CLEC9A

Swissprot: Q6UXN8
Gene Accession: NP997228.1

Calculated MW: 27 kDa
Observed MW: Refer to figures

Purification Method: Antigen affinity purification

Buffer: PBS with 0.05% NaN3 and 40% Glycerol, pH7.4

Concentration: 0.96 mg/mL
Dilution: WB 1:500-1:2000, ELISA 1:5000-1:10000

Storage:
Store at -20°C. Avoid freeze / thaw cycles.